X0306 4 2019-05-16 0 0000891293 CTI BIOPHARMA CORP ctic 0001339498 Craig Adam R C/O CTI BIOPHARMA CORP. 3101 WESTERN AVE., SUITE 800 SEATTLE WA 98121 1 1 0 0 President and CEO Non-Qualified Stock Option (right to buy) 0.8411 2019-05-16 4 A 0 1300000 0 A 2029-05-16 Common Stock 1300000 1300000 D One-third of the shares underlying the option will vest on February 19, 2020, and one-third of the shares underlying the option will vest annually thereafter, such that all of the shares subject to the option will be vested and exercisable on February 19, 2022, subject to Dr. Craig continuing to be an employee or a service provider through each such date. Bruce J. Seeley, Attorney-in-fact For: Adam R. Craig 2019-05-20